Clinical trial
ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
NCT00161070 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00161070 |
|---|---|
| Title | ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial |
| Official title | ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial |
| Lead sponsor | UMC Utrecht, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Brain Ischemia, Transient Ischemic Attack, Arteriosclerosis |
| Intervention type | Drug |
| Interventions | anticoagulation, aspirin and dipyridamole, aspirin alone |
| Enrollment | 4,500 |
| Start date | Jul 1, 1997 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 22, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: